MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 10.11.2022
Land |
 Vereinigte Staaten |
IPO-Jahr |
2014 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
63.4 M |
Marktkapitalisierung |
$ 4.68 M |
EBITDA (LTM) |
$ -48.1 M |
P/E (LTM) |
- |
P/S (LTM) |
25.3 |
EPS (LTM) |
-0.76 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
BioNTech SE
BNTX
|
$ 95.5 | - | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | USA |
 |
Edesa Biotech
EDSA
|
$ 15.46 | - | $ 49.4 M | Nasdaq Capital Market | USA |
 |
Esperion Therapeutics
ESPR
|
$ 3.11 | - | $ 646 M | Nasdaq Global Market,SPB | USA |
 |
Exelixis
EXEL
|
$ 44.42 | - | $ 12.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Fortress Biotech
FBIO
|
$ 2.46 | - | $ 68.6 M | Nasdaq Capital Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 6.72 | - | $ 192 M | Nasdaq Capital Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 2.23 | - | $ 143 M | Nasdaq Global Select Market | USA |
 |
Genprex
GNPX
|
$ 0.89 | - | $ 830 K | Nasdaq Capital Market | USA |
 |
Hutchison China MediTech Limited
HCM
|
$ 13.3 | - | $ 11.4 B | Nasdaq Global Select Market | China |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |
 |
Immuron Limited
IMRN
|
$ 0.79 | - | $ 8.53 M | Nasdaq Global Select Market |  Australia |
 |
INmune Bio
INMB
|
$ 1.54 | - | $ 38.1 M | Nasdaq Capital Market | USA |
 |
Ionis Pharmaceuticals
IONS
|
$ 75.25 | - | $ 12 B | Nasdaq Global Select Market,SPB | USA |
 |
KalVista Pharmaceuticals
KALV
|
$ 26.71 | - | $ 1.44 B | Nasdaq Global Select Market | Britain |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 22.35 | - | $ 3.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Kamada Ltd.
KMDA
|
$ 8.21 | - | $ 260 M | Nasdaq Global Select Market |  Israel |
 |
Kymera Therapeutics
KYMR
|
$ 82.71 | - | $ 6.99 B | Nasdaq Global Market | USA |
 |
Galapagos NV
GLPG
|
$ 28.39 | - | $ 2.69 B | Nasdaq Global Select Market |  Belgium |
 |
Grifols, S.A.
GRFS
|
$ 8.27 | - | $ 6.83 B | Nasdaq Global Select Market |  Spain |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 3.5 | - | $ 5.76 M | NYSE American | Israel |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 105.81 | - | $ 5.31 B | Nasdaq Global Select Market | USA |
 |
MannKind Corporation
MNKD
|
$ 2.86 | - | $ 874 M | Nasdaq Global Market | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.97 | - | $ 152 M | Nasdaq Global Select Market | Germany |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 23.42 | - | $ 2.98 B | Nasdaq Global Select Market,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 34.77 | - | $ 286 B | Nasdaq Global Select Market | France |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |